tetano
Editor, Senior Moderator
Cureus
. 2022 Jan 8;14(1):e21026.
doi: 10.7759/cureus.21026. eCollection 2022 Jan.
COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia
Hamza Jan[SUP] 1 [/SUP], Abdullah Waheeb[SUP] 1 [/SUP], Hatem AlAhwal[SUP] 1 2 [/SUP], Abdullah Almohammadi[SUP] 1 2 [/SUP], Adel Al-Marzouki[SUP] 1 2 [/SUP], Ahmed Barefah[SUP] 1 2 [/SUP], Salem Bahashawan[SUP] 1 2 [/SUP], Osman Radhwi[SUP] 1 2 [/SUP]
Affiliations
Abstract
Background: In the era of the coronavirus disease-2019 (COVID-19) pandemic, the race toward shielding the public through vaccination is still going. Patients with sickle cell disease (SCD) require special consideration given their medical needs and the common side effects of immunization, affecting their decision. Therefore, we aimed to assess the perception and hesitancy toward COVID-19 vaccination in this population and explore the possible factors when it comes to vaccination decisions.
Methods: The present cross-sectional phone interview study was conducted between May 10 and 20, 2021. The questionnaire was administered by the medical staff. The participants were all patients with SCD presented to King Abdulaziz University Hospital in Jeddah, Saudi Arabia. Results: Out of 346 patients, 147 patients agreed to participate. Only 52 (35.37%) patients received at least one dose of the nationally available vaccines, and there were no reported serious side effects. Among the unvaccinated participants, 45 patients (47.8%) were undecided. The most reported reasons for hesitancy were the fear of developing complications as their acquaintance had and the fear of developing brain blood clots post vaccination.
Conclusions: The number of vaccinated patients with SCD was unfortunately low in our study, secondary to hesitancy. This represents a significant barrier and needs to be tackled appropriately at any proper interaction with a patient with SCD. The absence of major side effects and vaso-occlusive crises is assuring.
Keywords: covid-19; covid-19 vaccination hesitancy; covid-19 vaccine; jeddah saudi arabia; sickle cell disease: scd.
. 2022 Jan 8;14(1):e21026.
doi: 10.7759/cureus.21026. eCollection 2022 Jan.
COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia
Hamza Jan[SUP] 1 [/SUP], Abdullah Waheeb[SUP] 1 [/SUP], Hatem AlAhwal[SUP] 1 2 [/SUP], Abdullah Almohammadi[SUP] 1 2 [/SUP], Adel Al-Marzouki[SUP] 1 2 [/SUP], Ahmed Barefah[SUP] 1 2 [/SUP], Salem Bahashawan[SUP] 1 2 [/SUP], Osman Radhwi[SUP] 1 2 [/SUP]
Affiliations
- PMID: 35154996
- PMCID: PMC8820497
- DOI: 10.7759/cureus.21026
Abstract
Background: In the era of the coronavirus disease-2019 (COVID-19) pandemic, the race toward shielding the public through vaccination is still going. Patients with sickle cell disease (SCD) require special consideration given their medical needs and the common side effects of immunization, affecting their decision. Therefore, we aimed to assess the perception and hesitancy toward COVID-19 vaccination in this population and explore the possible factors when it comes to vaccination decisions.
Methods: The present cross-sectional phone interview study was conducted between May 10 and 20, 2021. The questionnaire was administered by the medical staff. The participants were all patients with SCD presented to King Abdulaziz University Hospital in Jeddah, Saudi Arabia. Results: Out of 346 patients, 147 patients agreed to participate. Only 52 (35.37%) patients received at least one dose of the nationally available vaccines, and there were no reported serious side effects. Among the unvaccinated participants, 45 patients (47.8%) were undecided. The most reported reasons for hesitancy were the fear of developing complications as their acquaintance had and the fear of developing brain blood clots post vaccination.
Conclusions: The number of vaccinated patients with SCD was unfortunately low in our study, secondary to hesitancy. This represents a significant barrier and needs to be tackled appropriately at any proper interaction with a patient with SCD. The absence of major side effects and vaso-occlusive crises is assuring.
Keywords: covid-19; covid-19 vaccination hesitancy; covid-19 vaccine; jeddah saudi arabia; sickle cell disease: scd.